We are live on
!
Find out more
ACM
Atika Capital Management Portfolio holdings
AUM
$796M
1-Year Est. Return
167.57%
This Fund
S&P 500
This Quarter
Est. Return
+16.02%
1 Year Est. Return
+167.57%
3 Year Est. Return
+553.47%
5 Year Est. Return
+1,283.26%
10 Year Est. Return
+44,203.78%
AUM
$677M
AUM Growth
-$18.3M
(-2.6%)
Cap. Flow
-$59.8M
Cap. Flow
% of AUM
-8.82%
Top 10 Holdings %
Top 10 Hldgs %
40.24%
Holding
97
New
32
Increased
12
Reduced
30
Closed
20
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tradeweb Markets
TW
|
+$11.6M |
| 2 |
Mercado Libre
MELI
|
+$11.3M |
| 3 |
TSMC
TSM
|
+$11.2M |
| 4 |
Sherwin-Williams
SHW
|
+$11.1M |
| 5 |
CTLT
CATALENT, INC.
CTLT
|
+$9.36M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Clearfield
CLFD
|
+$23.9M |
| 2 |
T-Mobile US
TMUS
|
+$20.7M |
| 3 |
United Therapeutics
UTHR
|
+$15.1M |
| 4 |
VISN
Vistance Networks Inc
VISN
|
+$14.2M |
| 5 |
Calix
CALX
|
+$13.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.99% |
| 2 | Healthcare | 30.28% |
| 3 | Communication Services | 9.67% |
| 4 | Materials | 5.83% |
| 5 | Industrials | 4.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HCP
51
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
| $4.42M | 0.65% |
+151,000
| New | +$4.51M |
|
52
Blackbaud
BLKB
$2.08B
| $4.16M | 0.61% |
+60,000
| New | +$3.59M |
|
|
MPT
53
PUT
Medical Properties Trust
MPT
$2.81B
| $4.11M | 0.61% |
+5,000
| New | +$55.2K |
|
54
Jazz Pharmaceuticals
JAZZ
$16.7B
| $3.88M | 0.57% |
26,500
-62,907
| -70% | -$9.31M |
|
55
CALL
Manchester United
MANU
$3.73B
| $3.81M | 0.56% |
+1,720
| New | +$39K |
|
56
Roivant Sciences
ROIV
$26.2B
| $3.58M | 0.53% |
485,000
-75,000
| -13% | -$618K |
|
57
Procore
PCOR
$8.67B
| $2.97M | 0.44% |
47,500
+24,040
| +102% | +$1.41M |
|
58
Datadog
DDOG
$84B
| $2.91M | 0.43% |
+40,000
| New | +$2.94M |
|
59
Pliant Therapeutics
PLRX
$65M
| $2.9M | 0.43% |
+109,190
| New | +$3.11M |
|
|
ITCI
60
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $2.87M | 0.42% |
53,000
-66,000
| -55% | -$3.19M |
|
61
FIVE9
FIVN
$2.54B
| $2.82M | 0.42% |
39,000
-46,800
| -55% | -$3.35M |
|
62
Cytokinetics
CYTK
$10.4B
| $2.64M | 0.39% |
75,063
+9,063
| +14% | +$370K |
|
|
GTLS
63
DELISTED
Chart Industries
GTLS
| $2.57M | 0.38% |
+20,500
| New | +$2.64M |
|
64
Xenon Pharmaceuticals
XENE
$6.12B
| $2.41M | 0.36% |
+67,450
| New | +$2.49M |
|
65
Prothena Corp
PRTA
$450M
| $2.35M | 0.35% |
48,578
-42,600
| -47% | -$2.25M |
|
|
66
Clearfield
CLFD
$374M
| $2.12M | 0.31% |
45,600
-370,500
| -89% | -$23.9M |
|
|
VISN
67
CALL
Vistance Networks Inc
VISN
$2.52B
| $1.91M | 0.28% |
3,000
-3,000
| -50% | -$22.7K |
|
68
HubSpot
HUBS
$10.5B
| $1.87M | 0.28% |
+4,350
| New | +$1.59M |
|
|
WAVC.U
69
DELISTED
Waverley Capital Acquisition Corp. 1 Units, each consisting of one Class A Ordinary Share and one-third of one redeemable warrant
WAVC.U
| $1.82M | 0.27% |
177,909
-9,364
| -5% | -$95.2K |
|
70
CALL
BridgeBio Pharma
BBIO
$16.5B
| $1.69M | 0.25% |
+1,020
| New | +$11.9K |
|
|
TAST
71
DELISTED
Carrols Restaurant Group, Inc.
TAST
| $1.63M | 0.24% |
731,892
-17,578
| -2% | -$35.7K |
|
|
GBIO
72
DELISTED
Generation Bio
GBIO
| $1.53M | 0.23% |
+35,500
| New | +$1.72M |
|
|
73
BridgeBio Pharma
BBIO
$16.5B
| $1.49M | 0.22% |
+90,000
| New | +$1.05M |
|
|
FRC
74
PUT
DELISTED
First Republic Bank
FRC
| $1.4M | 0.21% |
+1,000
| New | +$102K |
|
75
Amazon
AMZN
$2.96T
| $413K | 0.06% |
+4,000
| New | +$386K |
|
Similar funds
AGA
ACM
LSA
GWA
HP
SC
IAM
VCM
Atika Capital Management's Q1 2023 Portfolio in Review
As of Q1 2023, Atika Capital Management held 97 positions worth $677M, down 2.6% from $695M the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Atika Capital Management withdrew a net $59.8M in Q1 2023, closing 20 positions and reducing 30 holdings. Its most notable exit was T-Mobile US, an estimated $20.7M position sold in full.
By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 32% a quarter earlier, followed by Healthcare and Communication Services.
Against the trend, Atika Capital Management opened a new position in Tradeweb Markets worth $12.6M.
- Atika Capital Management's largest Q1 2023 buy was Tradeweb Markets: 160,000 shares worth $12.6M.
- Atika Capital Management added most to Microsoft in Q1 2023, an estimated $9.23M increase.
- Atika Capital Management's biggest Q1 2023 reduction was Clearfield, cutting an estimated $23.9M.
- Atika Capital Management fully exited T-Mobile US in Q1 2023, selling an estimated $20.7M.
- Atika Capital Management's ten largest holdings make up 40% of its $677M portfolio in Q1 2023.
- Atika Capital Management opened 32 new positions and closed 20 in Q1 2023.
- Atika Capital Management's portfolio value fell 2.6% quarter-over-quarter to $677M.
Based on Atika Capital Management's 13F filing for Q1 2023, filed 12 May 2023.